Press releases
- Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
- Haemonetics Announces Proposed Convertible Senior Notes Offering
- Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
- Haemonetics Corporation Completes Acquisition of Attune Medical
- Haemonetics Announces Definitive Agreement to Acquire Attune Medical
More ▼
Key statistics
As of last trade Haemonetics Corp (HAZ:DUS) traded at 80.00, 7.38% above its 52-week low of 74.50, set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 80.00 |
---|---|
High | 80.00 |
Low | 80.00 |
Bid | 80.00 |
Offer | 83.50 |
Previous close | 80.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 50.84m |
Free float | 50.45m |
P/E (TTM) | 38.89 |
Market cap | 4.52bn USD |
EPS (TTM) | 2.29 USD |
Data delayed at least 15 minutes, as of May 29 2024 08:30 BST.
More ▼